Back Our Bureau
AstraZeneca Pharma India Ltd has informed the BSE that its board on Tuesday approved a 1:5 stock split. The company seeks to split its shares of Rs 10 each into five shares of Rs 2 each. It has called an EGM on June 6 for final approval. Post-split, the authorised capital of Rs 5 crore, as per the Memorandum and Articles of Association, would stand divided into 2.5 crore equity shares of the face value of Rs 2 each.
© Copyright 2000 - 2009 The Hindu Business Line |